312 related articles for article (PubMed ID: 26743314)
1. The PB1 segment of an influenza A virus H1N1 2009pdm isolate enhances the replication efficiency of specific influenza vaccine strains in cell culture and embryonated eggs.
Mostafa A; Kanrai P; Ziebuhr J; Pleschka S
J Gen Virol; 2016 Mar; 97(3):620-631. PubMed ID: 26743314
[TBL] [Abstract][Full Text] [Related]
2. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
3. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
Pan W; Dong Z; Meng W; Zhang W; Li T; Li C; Zhang B; Chen L
Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
[TBL] [Abstract][Full Text] [Related]
4. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.
Abt M; de Jonge J; Laue M; Wolff T
Vaccine; 2011 Jul; 29(32):5153-62. PubMed ID: 21624413
[TBL] [Abstract][Full Text] [Related]
5. Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
Hussain S; Turnbull ML; Pinto RM; McCauley JW; Engelhardt OG; Digard P
J Gen Virol; 2019 Jul; 100(7):1079-1092. PubMed ID: 31169484
[TBL] [Abstract][Full Text] [Related]
6. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
Lu B; Zhou H; Ye D; Kemble G; Jin H
J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
[TBL] [Abstract][Full Text] [Related]
7. Molecular signature of high yield (growth) influenza a virus reassortants prepared as candidate vaccine seeds.
Ramanunninair M; Le J; Onodera S; Fulvini AA; Pokorny BA; Silverman J; Devis R; Arroyo JM; He Y; Boyne A; Bera J; Halpin R; Hine E; Spiro DJ; Bucher D
PLoS One; 2013; 8(6):e65955. PubMed ID: 23776579
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical residues in the hemagglutinin and neuraminidase of influenza virus H1N1pdm for vaccine virus replication in embryonated chicken eggs.
Wang W; Lu J; Cotter CR; Wen K; Jin H; Chen Z
J Virol; 2013 Apr; 87(8):4642-9. PubMed ID: 23408613
[TBL] [Abstract][Full Text] [Related]
9. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
10. Development of high-yield influenza A virus vaccine viruses.
Ping J; Lopes TJS; Nidom CA; Ghedin E; Macken CA; Fitch A; Imai M; Maher EA; Neumann G; Kawaoka Y
Nat Commun; 2015 Sep; 6():8148. PubMed ID: 26334134
[TBL] [Abstract][Full Text] [Related]
11. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
12. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
13. Surveillance in Eastern India (2007-2009) revealed reassortment event involving NS and PB1-F2 gene segments among co-circulating influenza A subtypes.
Sarkar M; Chanda S; Chakrabarti S; Mazumdar J; Ganguly A; Chadha MS; Mishra AC; Chawla-Sarkar M
Virol J; 2012 Jan; 9():3. PubMed ID: 22217077
[TBL] [Abstract][Full Text] [Related]
14. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
[TBL] [Abstract][Full Text] [Related]
15. Heterologous Packaging Signals on Segment 4, but Not Segment 6 or Segment 8, Limit Influenza A Virus Reassortment.
White MC; Steel J; Lowen AC
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331085
[TBL] [Abstract][Full Text] [Related]
16. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
Li X; Gao Y; Ye Z
J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
[TBL] [Abstract][Full Text] [Related]
17. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
18. Is a highly pathogenic avian influenza virus H5N1 fragment recombined in PB1 the key for the epidemic of the novel AIV H7N9 in China, 2013?
Chen L; Sun L; Li R; Chen Y; Zhang Z; Xiong C; Zhao G; Jiang Q
Int J Infect Dis; 2016 Feb; 43():85-89. PubMed ID: 26778522
[TBL] [Abstract][Full Text] [Related]
19. H5N8 and H7N9 packaging signals constrain HA reassortment with a seasonal H3N2 influenza A virus.
White MC; Tao H; Steel J; Lowen AC
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4611-4618. PubMed ID: 30760600
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
Barman S; Krylov PS; Turner JC; Franks J; Webster RG; Husain M; Webby RJ
Vaccine; 2017 Mar; 35(10):1424-1430. PubMed ID: 28162820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
